THE ROLE OF NUTRITIONAL INTERVENTIONS AND SUPPLEMENTATION IN CHRONIC KIDNEY DISEASE – A NARRATIVE REVIEW
Authors:
- Zofia JedraZJZofia Jedra
- Maciej CzapiukMCMaciej Czapiuk
- Maciej Jakub KozickiMKMaciej Jakub Kozicki
- Damian ZienkiewiczDZDamian Zienkiewicz
- Julia Maria KostroJKJulia Maria Kostro
- Gabriela MakulecGMGabriela Makulec
- Karolina DomosudKDKarolina Domosud
- Anna LiberaALAnna Libera
- Karolina BartkiewiczKBKarolina Bartkiewicz
- Lizaveta NovikLNLizaveta Novik
Open Access
- 16 June 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Abstract
Background: Chronic kidney disease (CKD) affects approximately 10% of the population and is associated with increased cardiovascular risk and mortality. In advanced stages, protein-energy wasting (PEW) and malnutrition-inflammation complex syndrome (MICS) are common and worsen clinical outcomes. Evidence suggests that nutritional interventions, including modification of protein, sodium, potassium, and phosphorus intake, and selected supplementation, may slow CKD progression and reduce metabolic complications. Aim: This review summarizes current evidence on nutritional interventions and supplementation in CKD, considering disease stage and treatment modality, and identifies gaps requiring further research. Materials and methods: A narrative review of international guidelines (KDIGO, KDOQI, ESPEN) and clinical trials and meta-analyses published between 2009-2026, identified through searches of PubMed, Cochrane Library, Scopus, and Google Scholar, focusing on CKD stages G3-G5. Results: Individualized protein restriction, sodium limitation, and qualitative phosphorus control improve metabolic parameters, blood pressure and albuminuria. Low- and very low-protein diets, particularly with amino acid ketoanalogue supplementation, are associated with slower CKD progression and a delayed initiation of renal replacement therapy. Plant-based diets may additionally improve acid-base balance, phosphate metabolism, and inflammation. The strongest evidence for supplementation concerns vitamin D, iron, and amino acid ketoanalogues, while data on omega-3 fatty acids, probiotics, and B vitamins remain inconclusive. Conclusions: Nutritional management is a key component of CKD care. Individualized dietary strategies and targeted supplementation may provide nephroprotective and metabolic benefits, although further high-quality randomized trials are needed to confirm effects on hard clinical endpoints.Keywords
This publication has 63 references indexed in Scilit:
- Efficacy and safety of ketoanalogue supplementation combined with protein-restricted diets in advanced chronic kidney disease: a systematic review and meta-analysisJournal Of Nephrology, 2024
- Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative reviewJournal Of Nephrology, 2023
- Interdialytic weight gain and educational/cognitive, counseling/behavioral and psychological/affective interventions in patients on chronic hemodialysis: a systematic review and meta-analysisJournal Of Nephrology, 2022
- Phosphate intake, hyperphosphatemia, and kidney functionPflügers Archiv - European Journal of Physiology, 2022
- Altered dietary salt intake for people with chronic kidney diseaseCochrane Database of Systematic Reviews, 2021
- Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of GuidelinesCalcified Tissue International, 2021
- Low‐protein diet for conservative management of chronic kidney disease: a systematic review and meta‐analysis of controlled trialsJournal of Cachexia, Sarcopenia and Muscle, 2017
- Role of nutrition on anemia in elderlyClinical Nutrition ESPEN, 2016
- A comparison of actual versus stated label amounts of EPA and DHA in commercial omega‐3 dietary supplements in the United StatesJournal of the Science of Food and Agriculture, 2014
- Effect of Fish Oil Supplementation on Graft Patency and Cardiovascular Events Among Patients With New Synthetic Arteriovenous Hemodialysis GraftsJAMA, 2012